← Leaderboards
Richa Saxena
Massachusetts General Hospital
$14,473,362
Attributed
$22,203,641
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,203,641 · 12
By mechanism
R01$20,014,625 · 7
OT2$1,123,145 · 1
R21$961,831 · 3
F32$104,040 · 1
Top collaborators
- Frank A Scheer12 shared
- James Anthony Walker7 shared
- Girish C. Melkani6 shared
- Joyita Dutta4 shared
- Kathryn Johnson Gray1 shared
- Vesela Kovacheva1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jacqueline Marie Lane$4,108,548
- Sara Isabel Pai$12,404,338
- Yulia A. Levites Strekalova$2,152,417
- Timothy W Clark$3,927,002
- Ashley Cordes$1,797,771
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticGenome Wide Association StudyLinkTraitBiologicalSleepCohortGenesVariantBiobankBasePhenotypeGenetic RiskGenetic VariantInsightPathway InteractionsAffectPreventEtiologyFutureAlzheimer&AposRisk VariantCircadian RhythmsSleep Disturbances
Grant awards (44)
Ethical, multimodal AI tool for prediction of preeclampsia risk in early pregnancy$1,123,145
OT2 · FY2025 · OD
Genetics of chronotype and impact on metabolic disease$825,636
R01 · FY2025 · DK · contact PI
Genomics-guided sleep biomarker discovery for early Alzheimer's disease: A wearables study$772,900
R01 · FY2025 · AG
Integrative omics of preeclampsia in TOPMED and maternal cardiovascular health$729,563
R01 · FY2025 · HL · contact PI
Long COVID as a putative subtype of chronic fatigue syndrome$412,109
R01 · FY2025 · AI · contact PI
Long COVID as a putative subtype of chronic fatigue syndrome$349,946
R01 · FY2025 · AI · contact PI
Genomics-guided sleep biomarker discovery for early Alzheimer's disease: A wearables study$776,284
R01 · FY2024 · AG
Integrative omics of preeclampsia in TOPMED and maternal cardiovascular health$713,007
R01 · FY2024 · HL · contact PI
Long COVID as a putative subtype of chronic fatigue syndrome$351,594
R01 · FY2024 · AI · contact PI
Dissecting Causal Role of Insomnia in Cardiovascular Disease$749,769
R01 · FY2023 · HL · contact PI
Integrative omics of preeclampsia in TOPMED and maternal cardiovascular health$704,765
R01 · FY2023 · HL · contact PI
Long COVID as a putative subtype of chronic fatigue syndrome$353,193
R01 · FY2023 · AI · contact PI
Dissecting Causal Role of Insomnia in Cardiovascular Disease$756,108
R01 · FY2022 · HL · contact PI
Integrative omics of preeclampsia in TOPMED and maternal cardiovascular health$699,338
R01 · FY2022 · HL · contact PI
Dissecting Causal Role of Insomnia in Cardiovascular Disease$408,747
R01 · FY2022 · HL · contact PI
Long COVID as a putative subtype of chronic fatigue syndrome$370,568
R01 · FY2022 · AI · contact PI
Dissecting Causal Role of Insomnia in Cardiovascular Disease$72,778
R01 · FY2022 · HL · contact PI
Dissecting Causal Role of Insomnia in Cardiovascular Disease$754,188
R01 · FY2021 · HL · contact PI
Dissecting Causal Role of Insomnia in Cardiovascular Disease$74,267
R01 · FY2021 · HL · contact PI
Sleep metrics from machine learning for Alzheimer's disease diagnostics$14,807
R21 · FY2021 · AG
Dissecting Causal Role of Insomnia in Cardiovascular Disease$775,399
R01 · FY2020 · HL · contact PI
Impact of Malatonin, Food Timing and Receptor Variant on Type 2 Diabetes Risk$640,280
R01 · FY2020 · DK · contact PI
Genetics of chronotype and impact on metabolic disease$427,500
R01 · FY2020 · DK · contact PI
Sleep metrics from machine learning for Alzheimer's disease diagnostics$256,922
R21 · FY2020 · AG
Genetics of chronotype and impact on metabolic disease$168,000
R01 · FY2020 · DK · contact PI
Melatonin and Receptor Gene Variant: Linking Circadian System and Type 2 Diabetes$756,428
R01 · FY2019 · DK
Impact of Malatonin, Food Timing and Receptor Variant on Type 2 Diabetes Risk$640,280
R01 · FY2019 · DK · contact PI
Genetics of chronotype and impact on metabolic disease$427,500
R01 · FY2019 · DK · contact PI
Melatonin and Receptor Gene Variant: Linking Circadian System and Type 2 Diabetes$756,428
R01 · FY2018 · DK
Impact of malatonin, food timing and receptor variant on type 2 diabetes risk$640,280
R01 · FY2018 · DK · contact PI
Genetics of chronotype and impact on metabolic disease$427,500
R01 · FY2018 · DK · contact PI
Melatonin and Receptor Gene Variant: Linking Circadian System and Type 2 Diabetes$762,143
R01 · FY2017 · DK
Impact of malatonin, food timing and receptor variant on type 2 diabetes risk$640,280
R01 · FY2017 · DK · contact PI
Genetics of chronotype and impact on metabolic disease$427,500
R01 · FY2017 · DK · contact PI
Melatonin and Receptor Gene Variant: Linking Circadian System and Type 2 Diabetes$763,258
R01 · FY2016 · DK
Impact of malatonin, food timing and receptor variant on type 2 diabetes risk$677,280
R01 · FY2016 · DK · contact PI
Genetics of chronotype and impact on metabolic disease$427,500
R01 · FY2016 · DK · contact PI
Melatonin and Receptor Gene Variant: Linking Circadian System and Type 2 Diabetes$782,309
R01 · FY2015 · DK
Discovery of genes for sleep traits$128,542
R21 · FY2015 · HL · contact PI
Discovery of genes for sleep traits$130,500
R21 · FY2014 · HL · contact PI
Impact of MTNR1B and CRY2 variants on sleep circadian physiology and metabolism$181,614
R21 · FY2011 · DK · contact PI
Impact of MTNR1B and CRY2 variants on sleep circadian physiology and metabolism$249,446
R21 · FY2010 · DK · contact PI
Mitochondrial Variation and risk of T2DM$53,492
F32 · FY2005 · DK
Mitochondrial Variation and risk of T2DM$50,548
F32 · FY2004 · DK